Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Dmitry Ghilarov

Dmitry Ghilarov

Bacterial molecular machines leading to novel therapeutics

Bacterial diversity produces fascinating examples of protein machines with unique enzymatic activities, many of which could be inhibited to create new antibacterials. Our research aims to reveal fundamental principles of how bacterial
molecular machines work, and to learn how they could be manipulated and engineered. We are pursuing three main research directions, using a combination of biochemistry & structural biology methods:

 

  1. RiPPs: genetically encoded peptides that are converted into bioactive molecules by multienzyme complexes.

     
  2. Bacterial DNA topoisomerases - type II topoisomerases gyrase and topoisomerase IV that work in close connection with the replisome and SMC proteins, directly and indirectly affecting all genomic transactions in the cell.

     
  3. Bacterial antiviral defense systems - the field of bacterial phage immunity is one of the most exciting topics of contemporary microbiology. We are studying a complex defense system called BREX (bacteriophage exclusion system).